|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abgenix Inc., of Fremont, Calif., named Raymond Withy CEO effective May 1, succeeding R. Scott Greer, who will remain as chairman of the board. Withy is currently AbgenixEs president and chief operating officer, and has been an Abgenix officer since its founding in 1996. Abgenix develops human monoclonal antibody therapies.
Acacia Research Corp., of Newport Beach, Calif., said subsidiary CombiMatrix Corp., of Snoqualmie, Wash., reported that its Japanese subsidiary, CombiMatrix KK, entered into a technology access and purchase agreement with the Computational Biology Research Center, a division of the Japanese National Institute of Advanced Industrial Science and ...
Related newspaper, magazine, and journal articles:
|
|
Article: OSI Pharmaceuticals Signs Agreement to Acquire Cell ...
Business Wire;
February 10, 2003 ;
700+ words
... ... whereby OSI has agreed to acquire Cell Pathways, Inc. (NASDAQ: CLPA) via a ... shares of OSI for every share of Cell Pathways upon closing of the transaction, which is subject to Cell Pathways stockholder approval and is estimated ...
|
|